BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9576226)

  • 21. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of esmolol and fentanyl in controlling increases in heart rate and blood pressure during endotracheal intubation.
    Gaubatz CL; Wehner RJ
    AANA J; 1991 Feb; 59(1):91-6. PubMed ID: 1672049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
    Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
    Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of esmolol and labetalol for the treatment of perioperative hypertension in geriatric ambulatory surgical patients.
    Singh PP; Dimich I; Sampson I; Sonnenklar N
    Can J Anaesth; 1992 Jul; 39(6):559-62. PubMed ID: 1353708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children.
    Cuneo BF; Zales VR; Blahunka PC; Benson DW
    Pediatr Cardiol; 1994; 15(6):296-301. PubMed ID: 7838803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration.
    Abdullah EE; Pollick C
    Int J Card Imaging; 1997 Feb; 13(1):53-7. PubMed ID: 9080239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esmolol and beta-adrenergic blockade.
    Wolman RL; Fiedler MA
    AANA J; 1991 Dec; 59(6):541-8. PubMed ID: 1686346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion (PVC-CONTHY-CAP) in combination with ultra-short beta-blockade and nitroglycerine.
    Borowski A; Korb H
    Thorac Cardiovasc Surg; 1997 Apr; 45(2):51-4. PubMed ID: 9175218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics and therapeutic efficacy of esmolol.
    Wiest DB; Haney JS
    Clin Pharmacokinet; 2012 Jun; 51(6):347-56. PubMed ID: 22515557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.
    Wiest D
    Clin Pharmacokinet; 1995 Mar; 28(3):190-202. PubMed ID: 7758250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of repair of coarctation of the aorta during infancy.
    Williams WG; Shindo G; Trusler GA; Dische MR; Olley PM
    J Thorac Cardiovasc Surg; 1980 Apr; 79(4):603-8. PubMed ID: 6987464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation.
    Bensky KP; Donahue-Spencer L; Hertz GE; Anderson MT; James R
    AANA J; 2000 Oct; 68(5):437-42. PubMed ID: 11759128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina.
    Barth C; Ojile M; Pearson AC; Labovitz AJ
    Am Heart J; 1991 Mar; 121(3 Pt 1):782-8. PubMed ID: 1672051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Strategies for Paradoxical Hypertension Following Surgical Correction of Coarctation of the Aorta in Children.
    Roeleveld PP; Zwijsen EG
    World J Pediatr Congenit Heart Surg; 2017 May; 8(3):321-331. PubMed ID: 28520538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous nicardipine for treatment of postcoarctectomy hypertension in children.
    Nakagawa TA; Sartori SC; Morris A; Schneider DS
    Pediatr Cardiol; 2004; 25(1):26-30. PubMed ID: 14534761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparison of propranolol with esmolol for the treatment of tachycardia during emergence from anesthesia].
    Mizutani K; Nakamura C; Tsuchiya M; Asada A
    Masui; 2005 Jun; 54(6):632-7. PubMed ID: 15966380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esmolol in the treatment of supraventricular tachyarrhythmias.
    Das G; Ferris J
    Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
    Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
    Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of different surgical procedures on hypertension after repair of coarctation.
    Giordano U; Giannico S; Turchetta A; Hammad F; Calzolari F; Calzolari A
    Cardiol Young; 2005 Oct; 15(5):477-80. PubMed ID: 16164785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.